Rosuvastatin Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials
• Forums

EMERALD (Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders)
Condition:   Lipid Disorder Intervention:   Drug: moderate- or high-intensity statin/ rosuvastatin Sponsor:   Wake Forest University Health Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 24, 2023 Category: Research Source Type: clinical trials